Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · National Healthcare (NHC)

NHC Reports 2025 Net Income of $120.0 Million, Revenue Up 16.1% to $1.5 Billion

Positive Impact 3 of 5 earnings Written later

National HealthCare Corporation reported results for the year and quarter ended December 31, 2025, in a press release furnished under Item 2.02. Full-year net operating revenues and grant income rose 16.1% to $1.5 billion, and GAAP net income attributable to NHC rose to $120.0 million from $101.9 million. For shareholders, both revenue and reported profit increased, though the filing notes that the year's GAAP results include unrealized gains on marketable equity securities.

Key points

  • FY2025 net operating revenues and grant income: $1,517,781,000, up from $1,307,382,000 in 2024
  • FY2025 GAAP net income attributable to NHC: $120,015,000 (diluted EPS $7.67), up from $101,927,000 in 2024
  • FY2025 adjusted diluted EPS: $6.65, compared with $4.93 in 2024
  • Q4 2025 GAAP diluted EPS: $1.58, compared with $0.39 in Q4 2024; Q4 adjusted diluted EPS: $1.83, compared with $1.66

The filing

CompanyNational Healthcare (NHC)
Form8-K, current report
Filed with the SECFeb 27, 2026, 9:47 AM ET
Accession number0001437749-26-006000

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:38 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 27, 2026.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.